Prospective multicenter trial for efficacy of potassium competitive acid blocker to reduce delayed bleeding after gastric endoscopic submucosal dissection in patients on antithrombotic therapy
Not Applicable
- Conditions
- Gastric neoplasm
- Registration Number
- JPRN-UMIN000020174
- Lead Sponsor
- Osaka Gut Forum (OGF)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. History of gastrectomy 2. Schedule of endoscopic treatment for esophageal or duodenal lesion concurrently. 3. History of endoscopic treatment for upper GI lesion in the past 28 days. 4. Schedule of endoscopic treatment for upper GI lesion within 28 days after the gastric ESD. 5. Systemic administration (intravenously or orally) of either one or more drugs of corticosteroid, anticoagulant agent. 6. Diagnosis of psychiatric diseases. 7. With active bacterial or fungus infection. 8. With uncontrollable hypertension. 9. Disqualified for the study by physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method